Male breast cancer (MBC) is extremely rare and accounts for less than 1% of all breast
malignancies. Therefore, clinical management of MBC is currently guided by research on …

Simple Summary Male breast cancer (MBC) is a rare disease. Genetic factors predispose to
male breast cancer. Germline and/or genetic and/or epigenetic alterations at the somatic …

Male breast cancer (MBC) is rare, accounting for less than 1% of all breast cancer but the
incidence has increased worldwide. Risk factors include increased longevity, obesity …

Simple Summary Male breast cancer is a rare disease, representing around 0.5% of the
malignances in men. Although they receive the same treatment as women with breast …

Purpose: Male breast cancer is rare, and its genomic landscape has yet to be fully
characterized. Lacking studies in men, treatment of males with breast cancer is extrapolated …

Male breast cancer (MBC) is an uncommon and poorly understood disease. Recent
molecular studies have shown important differences from female breast cancer which are …

Male breast cancer (MBC) is extremely rare and poorly characterized on the molecular level.
Using high-resolution genomic data, we aimed to characterize MBC by genomic imbalances …

Male breast cancer (MBC) is a rare tumor, accounting for less than 1% of all breast cancers.
In MBC, genetic predisposition plays an important role; however, only a few studies have …

Background Male breast cancer (MBC) is an uncommon and relatively uncharacterised
disease accounting for< 1% of all breast cancers. A significant proportion occurs in families …

Purpose Male breast cancer (BC) is rare, representing approximately 1% of cancers that
occur in men and approximately 1% of all BCs worldwide. Because male BC is rare, not …